Your browser doesn't support javascript.
loading
Coexistence of growth hormone, adrenocorticotropic hormone, and testosterone deficiency associated with coronavirus disease 2019: a case followed up for 15 months.
Yoshimura, Kai; Yamamoto, Masaaki; Inoue, Tomoya; Fukuoka, Hidenori; Iida, Keiji; Ogawa, Wataru.
Affiliation
  • Yoshimura K; Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa 675-8555, Japan.
  • Yamamoto M; Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.
  • Inoue T; Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.
  • Fukuoka H; Division of Diabetes and Endocrinology, Kobe University Hospital, Kobe 650-0017, Japan.
  • Iida K; Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa 675-8555, Japan.
  • Ogawa W; Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Endocr J ; 69(11): 1335-1342, 2022 Nov 28.
Article in En | MEDLINE | ID: mdl-35831125

Full text: 1 Database: MEDLINE Main subject: Human Growth Hormone / COVID-19 / COVID-19 Drug Treatment / Hypogonadism Type of study: Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Endocr J Journal subject: ENDOCRINOLOGIA Year: 2022 Type: Article Affiliation country: Japan

Full text: 1 Database: MEDLINE Main subject: Human Growth Hormone / COVID-19 / COVID-19 Drug Treatment / Hypogonadism Type of study: Risk_factors_studies Limits: Aged / Humans / Male Language: En Journal: Endocr J Journal subject: ENDOCRINOLOGIA Year: 2022 Type: Article Affiliation country: Japan